Last reviewed · How we verify
Bupivacaine Hydrochloride and Lidocaine
Bupivacaine Hydrochloride and Lidocaine is a Small molecule drug developed by Atlantic Health System. It is currently FDA-approved. Also known as: Marcaine and Lidocaine, ESP block.
At a glance
| Generic name | Bupivacaine Hydrochloride and Lidocaine |
|---|---|
| Also known as | Marcaine and Lidocaine, ESP block |
| Sponsor | Atlantic Health System |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Opioid Free and Opioid Based Anesthesia in Elective Lumbar Spine Surgery
- Mid-transverse Process Combined With Erector Spinae Block Versus Paravertebral Plane Block (NA)
- EXPAREL or Lidocane as Local Anesthetic in Patients Undergoing Pleuroscopy With Pleural Biopsy and Indwelling Pleural Catheter Placement (PHASE2)
- Effect of Bilateral Rhomboid Intercostal Block on Postoperative Pain After Breast Implant Surgery (NA)
- Sacral Erector Spinae Plane Block in Transurethral Prostate Resection Surgery (NA)
- Thoracic Epidural Analgesia With Bilateral Erector Spinae Plane Block in Radical Cystectomy Surgery (NA)
- Comparison of Post-Dural Puncture Headache After Spinal Anesthesia Using Median Versus Paramedian Approach (NA)
- Prospective Evaluation of Efficacy of Tumescent Steroid Infiltration in Mandibular Third Molar Surgery: a Split Mouth Randomized Study (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Bupivacaine Hydrochloride and Lidocaine CI brief — competitive landscape report
- Bupivacaine Hydrochloride and Lidocaine updates RSS · CI watch RSS
- Atlantic Health System portfolio CI
Frequently asked questions about Bupivacaine Hydrochloride and Lidocaine
What is Bupivacaine Hydrochloride and Lidocaine?
Bupivacaine Hydrochloride and Lidocaine is a Small molecule drug developed by Atlantic Health System.
Who makes Bupivacaine Hydrochloride and Lidocaine?
Bupivacaine Hydrochloride and Lidocaine is developed and marketed by Atlantic Health System (see full Atlantic Health System pipeline at /company/atlantic-health-system).
Is Bupivacaine Hydrochloride and Lidocaine also known as anything else?
Bupivacaine Hydrochloride and Lidocaine is also known as Marcaine and Lidocaine, ESP block.
What development phase is Bupivacaine Hydrochloride and Lidocaine in?
Bupivacaine Hydrochloride and Lidocaine is FDA-approved (marketed).
Related
- Manufacturer: Atlantic Health System — full pipeline
- Also known as: Marcaine and Lidocaine, ESP block
- Compare: Bupivacaine Hydrochloride and Lidocaine vs similar drugs
- Pricing: Bupivacaine Hydrochloride and Lidocaine cost, discount & access